We are live on ! Find out more
RCA

Resonant Capital Advisors Portfolio holdings

AUM $2.09B
1-Year Est. Return 20.07%
This Fund
S&P 500
This Quarter Est. Return
+14.07%
1 Year Est. Return
+20.07%
3 Year Est. Return
+50.65%
5 Year Est. Return
+54.9%
10 Year Est. Return
AUM
$422M
AUM Growth
+$71.5M
Cap. Flow
+$24.1M
Cap. Flow %
5.71%
Top 10 Hldgs %
47.33%
Holding
175
New
18
Increased
95
Reduced
39
Closed
4

Sector Composition

Rank Sector Weight
1 Technology 6.93%
2 Financials 5.5%
3 Healthcare 5.44%
4 Consumer Discretionary 3.05%
5 Consumer Staples 2.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RWL icon
26
Invesco S&P 500 Revenue ETF
RWL
$9.85B
$2.79M 0.66%
44,872
-4,364
-9% -$257K
PKW icon
27
Invesco BuyBack Achievers ETF
PKW
$1.76B
$2.72M 0.64%
37,130
-14,024
-27% -$933K
SLYV icon
28
State Street SPDR S&P 600 Small Cap Value ETF
SLYV
$5.07B
$2.71M 0.64%
+40,941
New +$2.43M
QCOM icon
29
Qualcomm
QCOM
$171B
$2.71M 0.64%
17,770
-1,280
-7% -$178K
DOCU
30
DocuSign
DOCU
$11B
$2.51M 0.59%
11,301
-268
-2% -$60.2K
PGR icon
31
Progressive
PGR
$123B
$2.5M 0.59%
25,303
+148
+0.6% +$14K
JPM icon
32
JPMorgan Chase
JPM
$950B
$2.44M 0.58%
19,170
+865
+5% +$96.7K
ACN icon
33
Accenture
ACN
$104B
$2.4M 0.57%
9,208
+21
+0.2% +$5.03K
DIS icon
34
Walt Disney
DIS
$170B
$2.34M 0.55%
12,927
+335
+3% +$48.1K
GOOG icon
35
Alphabet (Google) Class C
GOOG
$4.59T
$2.3M 0.55%
26,300
+700
+3% +$59.1K
PFE icon
36
Pfizer
PFE
$145B
$2.25M 0.53%
61,196
-968
-2% -$35.5K
JNJ icon
37
Johnson & Johnson
JNJ
$614B
$2.23M 0.53%
14,136
+626
+5% +$92.4K
V icon
38
Visa
V
$690B
$2.2M 0.52%
10,058
+319
+3% +$65.3K
PYPL icon
39
PayPal
PYPL
$50.1B
$2.15M 0.51%
9,164
-242
-3% -$50.1K
AMZN icon
40
Amazon
AMZN
$2.99T
$2.11M 0.5%
12,980
+520
+4% +$83K
CVS icon
41
CVS Health
CVS
$133B
$2.11M 0.5%
30,938
+7,255
+31% +$472K
DHR icon
42
Danaher
DHR
$137B
$2.08M 0.49%
10,554
-998
-9% -$200K
DG icon
43
Dollar General
DG
$28.1B
$2.04M 0.48%
9,675
+27
+0.3% +$5.77K
PNC icon
44
PNC Financial Services
PNC
$101B
$1.91M 0.45%
12,808
+62
+0.5% +$7.92K
ADP icon
45
Automatic Data Processing
ADP
$108B
$1.89M 0.45%
10,689
+52
+0.5% +$8.54K
ADI icon
46
Analog Devices
ADI
$185B
$1.86M 0.44%
12,599
+449
+4% +$59.6K
ORCL icon
47
Oracle
ORCL
$420B
$1.82M 0.43%
28,210
+1,446
+5% +$86.1K
XLNX
48
DELISTED
Xilinx Inc
XLNX
$1.8M 0.43%
12,735
+100
+0.8% +$13K
MUB icon
49
iShares National Muni Bond ETF
MUB
$45.4B
$1.8M 0.43%
15,373
+6,722
+78% +$781K
PEP icon
50
PepsiCo
PEP
$190B
$1.76M 0.42%
11,787
+62
+0.5% +$8.81K

Similar funds

Resonant Capital Advisors's Q4 2020 Portfolio in Review

As of Q4 2020, Resonant Capital Advisors held 175 positions worth $422M, up 20% from $351M the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Resonant Capital Advisors deployed $24.1M of net new capital in Q4 2020, opening 18 new positions and adding to 95 existing holdings. Its largest new stake was State Street SPDR S&P 600 Small Cap Value ETF: 40,941 shares worth $2.71M.

By sector, the portfolio is most concentrated in Technology at 6.9% of assets, down from 7.3% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Invesco BuyBack Achievers ETF, an estimated $933K trimmed.

  • Resonant Capital Advisors's largest Q4 2020 buy was State Street SPDR S&P 600 Small Cap Value ETF: 40,941 shares worth $2.71M.
  • Resonant Capital Advisors added most to iShares Core S&P 500 ETF in Q4 2020, an estimated $2.44M increase.
  • Resonant Capital Advisors's biggest Q4 2020 reduction was Invesco BuyBack Achievers ETF, cutting an estimated $933K.
  • Resonant Capital Advisors fully exited iShares iBonds Dec 2020 Term Corporate ETF in Q4 2020, selling an estimated $352K.
  • Resonant Capital Advisors's ten largest holdings make up 47% of its $422M portfolio in Q4 2020.
  • Resonant Capital Advisors opened 18 new positions and closed 4 in Q4 2020.
  • Resonant Capital Advisors's portfolio value rose 20% quarter-over-quarter to $422M.

Based on Resonant Capital Advisors's 13F filing for Q4 2020, filed 15 Jan 2021.